Literature DB >> 18246535

Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection.

Shiang-Fu Huang1, Chung-Jan Kang, Chen-Yu Lin, Kang-Hsing Fan, Tzu-Chen Yen, Hung-Ming Wang, I-How Chen, Chun-Ta Liao, Ann-Joy Cheng, Joseph Tung-Chieh Chang.   

Abstract

BACKGROUND: The role of elective and therapeutic selective neck dissection in patients with early stage cancer of the oral tongue remains controversial. The purpose was to investigate the role of neck treatment in the management of this condition.
METHODS: A total of 380 patients with cT1-2N0 oral tongue cancer were retrospectively reviewed. Patients were staged by means of computed tomography (CT) or magnetic resonance imaging (MRI) scans. A total of 324 patients received elective neck dissection (END), whereas 56 participants received observation (OBS). In all, 287 patients received supraomohyoid neck dissection (SOND), whereas 37 patients received modified radical neck dissection (MRND). Overall survival (OS) and neck control rates (NCR) were investigated according to the treatment modality.
RESULTS: In the END group the occult metastasis (OM) rates in cervical lymph nodes were 5.2% for cT1 lesions and 14.6% for cT2 lesion (P = .005). The 5-year OS (P = .029) and NCR rates (P = .001) were significantly better in the END group compared with the OBS group. Patients who received MRND had a better 5-year NCR compared with SOND, albeit not significantly (91.4% vs 85.3%, P = .415). Multivariate analysis showed that END and stage were independent predictors of both NCR and OS.
CONCLUSIONS: END should be performed routinely in patients with early-stage oral tongue cancer, even in the presence of negative neck by CT scans and MRI.

Entities:  

Mesh:

Year:  2008        PMID: 18246535     DOI: 10.1002/cncr.23278

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  33 in total

1.  The lingual lymph node identified as a sentinel node on CT lymphography in a patient with cN0 squamous cell carcinoma of the tongue.

Authors:  M Saito; H Nishiyama; Y Oda; S Shingaki; T Hayashi
Journal:  Dentomaxillofac Radiol       Date:  2011-11-10       Impact factor: 2.419

2.  Key architectural changes in tumor-negative lymph nodes from metastatic-free oral cancer patients are valuable prognostic factors.

Authors:  Marilena Vered; Ginette Schiby; Anna Schnaiderman-Shapiro; Ilya Novikov; Ibrahim O Bello; Tuula Salo; Aleksi Rytkönen; Joonas H Kauppila; Alex Dobriyan; Ran Yahalom; Shlomo Taicher; Dan Dayan
Journal:  Clin Exp Metastasis       Date:  2014-01-07       Impact factor: 5.150

3.  Perinerural, lymphovascular and depths of invasion in extrapolating nodal metastasis in oral cancer.

Authors:  Alkananda Sahoo; Swagatika Panda; Neeta Mohanty; Debkant Jena; Niranjan Mishra; Manas R Baisakh
Journal:  Clin Oral Investig       Date:  2019-05-28       Impact factor: 3.573

Review 4.  Cancer of the oral cavity.

Authors:  Pablo H Montero; Snehal G Patel
Journal:  Surg Oncol Clin N Am       Date:  2015-04-15       Impact factor: 3.495

5.  Elective neck dissection in T1/T2 oral squamous cell carcinoma with N0 neck: essential or not? A systematic review and meta-analysis.

Authors:  Samer Ahmed Ibrahim; Ahmed Nabil Abdelhamid Ahmed; Hisham Abdelaty Elsersy; Islam Mohammed Hussein Darahem
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-25       Impact factor: 2.503

6.  Outcomes after up-front surgery and metronomic neoadjuvant chemotherapy with S-1 or UFT for early tongue squamous cell carcinoma.

Authors:  Shinichiro Kina; Toshiyuki Nakasone; Takao Kinjo; Fumikazu Nimura; Nao Sunagawa; Akira Arasaki
Journal:  Clin Oral Investig       Date:  2018-10-13       Impact factor: 3.573

7.  Assessment of the Rate of Skip Metastasis to Neck Level IV in Patients With Clinically Node-Negative Neck Oral Cavity Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.

Authors:  Anton Warshavsky; Roni Rosen; Narin Nard-Carmel; Sara Abu-Ghanem; Yael Oestreicher-Kedem; Avraham Abergel; Dan M Fliss; Gilad Horowitz
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-06-01       Impact factor: 6.223

8.  Operable Oral Tongue Squamous Cell Cancer: 15 Years Experience at a Tertiary Care Center in North India.

Authors:  Nootan Kumar Shukla; S V Suryanarayana Deo; Pankaj Kumar Garg; N M L Manjunath; Suman Bhaskar; V Sreenivas
Journal:  Indian J Surg Oncol       Date:  2017-05-11

Review 9.  The diagnosis and treatment of oral cavity cancer.

Authors:  Klaus-Dietrich Wolff; Markus Follmann; Alexander Nast
Journal:  Dtsch Arztebl Int       Date:  2012-11-30       Impact factor: 5.594

10.  Outcome in recurrent head neck cancer treated with salvage-IMRT.

Authors:  Gabriela Studer; Klaus W Graetz; Christoph Glanzmann
Journal:  Radiat Oncol       Date:  2008-12-17       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.